|
|
||||||||
Eur J Cardiothorac Surg 2007;32:291-294. doi:10.1016/j.ejcts.2007.04.033
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved
The International Heart Institute of Montana Foundation at Saint Patrick Hospital and Health Sciences Center and The University of Montana, Missoula, Montana, USA
Received 27 August 2006; received in revised form 21 April 2007; accepted 23 April 2007.
* Corresponding author. Address: The International Heart Institute of Montana Foundation, 500 West Broadway, Suite 350, Missoula, MT 59802, USA. Tel.: +1 406 329 5668; fax: +1 406 329 5880. (Email: duran{at}saintpatrick.org).
Objective: Coronary flow obstruction is a serious complication reported in percutaneous aortic valve replacement. In an in vitro study of porcine hearts, the effects of valved stent implantation on coronary artery flow were studied with the native valve's leaflets intact and excised. Methods: The right and left main coronary arteries of porcine hearts were dissected 20 mm distal to the aortic root and directed into lengths of latex tubing leading to collection flasks. The ascending aorta was cut proximal to the brachiocephalic trunk, cannulated, and attached to a constant-head water supply. After steady flow was achieved, the flow rate from each coronary artery was measured. In Group A (n = 10), a tubular pericardial valve sutured into a cylindrical, cobalt–nickel stent was deployed orthotopically using a valvuloplasty balloon catheter. In Group B (n = 10), the native leaflets were removed before similar valve deployment. Coronary flow measurements were repeated post-implantation. Results: In Group A, valve implantation resulted in a significant decrease in both left and right coronary flows. In Group B, no significant change in either right or left coronary flow was found after valve placement. Conclusion: Implantation of a percutaneous valved stent in the orthotopic position with the native valve in place causes coronary ostial obstruction. This problem highlights the need for modified stents that are designed for implantation in patients with non-retracted, fibrotic, or calcified leaflets.
Key Words: Aortic valve Replacement Percutaneous Coronary artery flow
This article has been cited by other articles:
![]() |
S. Salizzoni, P. Bajona, K. J. Zehr, W. D. Anderson, S. Vandenberghe, and G. Speziali Transapical off-pump removal of the native aortic valve: a proof-of-concept animal study. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 468 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Quaden, T. Attmann, M. Schunke, D. Theisen-Kunde, J. Cremer, and G. Lutter Percutaneous aortic valve replacement: Endovascular resection of human aortic valves in situ. J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 1081 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Grunenfelder, A. Plass, H. Alkadhi, and M. Genoni Evaluation of biological aortic valve prostheses by dual source computer tomography and anatomic measurements for potential transapical valve-in-valve procedure Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 195 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Quaden and G. Lutter Editorial comment: Resection and new stents before valved stent implantation Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 295 - 295. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |